These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19366692)
1. BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. Matsuda S; Matsuda Y; D'Adamio L J Biol Chem; 2009 Jun; 284(23):15815-25. PubMed ID: 19366692 [TBL] [Abstract][Full Text] [Related]
2. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. Matsuda S; Giliberto L; Matsuda Y; Davies P; McGowan E; Pickford F; Ghiso J; Frangione B; D'Adamio L J Biol Chem; 2005 Aug; 280(32):28912-6. PubMed ID: 15983050 [TBL] [Abstract][Full Text] [Related]
3. BRI2 and BRI3 are functionally distinct phosphoproteins. Martins F; Rebelo S; Santos M; Cotrim CZ; da Cruz e Silva EF; da Cruz e Silva OA Cell Signal; 2016 Jan; 28(1):130-44. PubMed ID: 26515131 [TBL] [Abstract][Full Text] [Related]
4. BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. Matsuda S; Giliberto L; Matsuda Y; McGowan EM; D'Adamio L J Neurosci; 2008 Aug; 28(35):8668-76. PubMed ID: 18753367 [TBL] [Abstract][Full Text] [Related]
5. NRBP1-Containing CRL2/CRL4A Regulates Amyloid β Production by Targeting BRI2 and BRI3 for Degradation. Yasukawa T; Tsutsui A; Tomomori-Sato C; Sato S; Saraf A; Washburn MP; Florens L; Terada T; Shimizu K; Conaway RC; Conaway JW; Aso T Cell Rep; 2020 Mar; 30(10):3478-3491.e6. PubMed ID: 32160551 [TBL] [Abstract][Full Text] [Related]
6. CD74 interacts with APP and suppresses the production of Abeta. Matsuda S; Matsuda Y; D'Adamio L Mol Neurodegener; 2009 Oct; 4():41. PubMed ID: 19849849 [TBL] [Abstract][Full Text] [Related]
7. BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. Fotinopoulou A; Tsachaki M; Vlavaki M; Poulopoulos A; Rostagno A; Frangione B; Ghiso J; Efthimiopoulos S J Biol Chem; 2005 Sep; 280(35):30768-72. PubMed ID: 16027166 [TBL] [Abstract][Full Text] [Related]
8. β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. Tamayev R; Matsuda S; Arancio O; D'Adamio L EMBO Mol Med; 2012 Mar; 4(3):171-9. PubMed ID: 22170863 [TBL] [Abstract][Full Text] [Related]
9. A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission. Yin T; Yao W; Norris KA; D'Adamio L J Biol Chem; 2021 Sep; 297(3):101089. PubMed ID: 34416235 [TBL] [Abstract][Full Text] [Related]
11. Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Matsuda S; Matsuda Y; Snapp EL; D'Adamio L Neurobiol Aging; 2011 Aug; 32(8):1400-8. PubMed ID: 19748705 [TBL] [Abstract][Full Text] [Related]
12. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation. Xie Z; Dong Y; Maeda U; Xia W; Tanzi RE J Biol Chem; 2007 Feb; 282(7):4318-4325. PubMed ID: 17170108 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia. Tamayev R; D'Adamio L Mol Neurodegener; 2012 Apr; 7():19. PubMed ID: 22537414 [TBL] [Abstract][Full Text] [Related]
14. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424 [TBL] [Abstract][Full Text] [Related]
15. The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. Peng S; Fitzen M; Jörnvall H; Johansson J Biochem Biophys Res Commun; 2010 Mar; 393(3):356-61. PubMed ID: 20036644 [TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated silencing of X11alpha and X11beta attenuates amyloid beta-protein levels via differential effects on beta-amyloid precursor protein processing. Xie Z; Romano DM; Tanzi RE J Biol Chem; 2005 Apr; 280(15):15413-21. PubMed ID: 15699037 [TBL] [Abstract][Full Text] [Related]
17. BRI2 as an anti-Alzheimer gene. Matsuda S; Senda T Med Mol Morphol; 2019 Mar; 52(1):1-7. PubMed ID: 29687167 [TBL] [Abstract][Full Text] [Related]
18. The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ Dolfe L; Tambaro S; Tigro H; Del Campo M; Hoozemans JJM; Wiehager B; Graff C; Winblad B; Ankarcrona M; Kaldmäe M; Teunissen CE; Rönnbäck A; Johansson J; Presto J J Alzheimers Dis Rep; 2018 Feb; 2(1):27-39. PubMed ID: 30480246 [TBL] [Abstract][Full Text] [Related]
19. BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels. Tsachaki M; Fotinopoulou A; Slavi N; Zarkou V; Ghiso J; Efthimiopoulos S Curr Alzheimer Res; 2013 Jun; 10(5):532-41. PubMed ID: 23701002 [TBL] [Abstract][Full Text] [Related]
20. X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein. King GD; Cherian K; Turner RS J Neurochem; 2004 Feb; 88(4):971-82. PubMed ID: 14756819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]